| Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer B Vaidya, V Parvathaneni, NS Kulkarni, SK Shukla, JK Damon, A Sarode, ... International journal of biological macromolecules 122, 338-347, 2019 | 107 | 2019 |
| Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective D Solomon, N Gupta, NS Mulla, S Shukla, YA Guerrero, V Gupta The AAPS journal 19, 1669-1681, 2017 | 74 | 2017 |
| Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer X Wang, V Parvathaneni, SK Shukla, NS Kulkarni, A Muth, NK Kunda, ... International Journal of Biological Macromolecules 164, 638-650, 2020 | 70 | 2020 |
| Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics B Vaidya, NS Kulkarni, SK Shukla, V Parvathaneni, G Chauhan, ... International journal of pharmaceutics 577, 118995, 2020 | 62 | 2020 |
| Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment V Parvathaneni, NS Kulkarni, SK Shukla, PT Farrales, NK Kunda, A Muth, ... Pharmaceutics 12 (3), 206, 2020 | 61 | 2020 |
| Metformin-encapsulated liposome delivery system: an effective treatment approach against breast cancer SK Shukla, NS Kulkarni, A Chan, V Parvathaneni, P Farrales, A Muth, ... Pharmaceutics 11 (11), 559, 2019 | 60 | 2019 |
| Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability B Vaidya, SK Shukla, S Kolluru, M Huen, N Mulla, N Mehra, D Kanabar, ... Carbohydrate polymers 204, 68-77, 2019 | 54 | 2019 |
| Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer SK Shukla, NS Kulkarni, P Farrales, DD Kanabar, V Parvathaneni, ... Pharmaceutical research 37, 1-19, 2020 | 51 | 2020 |
| Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment NS Kulkarni, V Parvathaneni, SK Shukla, L Barasa, JC Perron, ... European Journal of Pharmaceutical Sciences 133, 145-159, 2019 | 51 | 2019 |
| Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy RS Elbatanony, V Parvathaneni, NS Kulkarni, SK Shukla, G Chauhan, ... Drug delivery and translational research 11, 927-943, 2021 | 47 | 2021 |
| Enhanced solubility, stability, permeation and anti-cancer efficacy of Celastrol-β-cyclodextrin inclusion complex SK Shukla, A Chan, V Parvathaneni, DD Kanabar, K Patel, S Ayehunie, ... Journal of Molecular Liquids 318, 113936, 2020 | 41 | 2020 |
| Cyclodextrin complexation for enhanced stability and non-invasive pulmonary delivery of resveratrol—applications in non-small cell lung cancer treatment X Wang, V Parvathaneni, SK Shukla, DD Kanabar, A Muth, V Gupta Aaps Pharmscitech 21, 1-14, 2020 | 35 | 2020 |
| Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma–a rare thoracic cancer SK Shukla, A Chan, V Parvathaneni, V Gupta International Journal of Biological Macromolecules 160, 128-141, 2020 | 34 | 2020 |
| Development of pharmaceutically scalable inhaled anti-cancer nanotherapy–repurposing amodiaquine for non-small cell lung cancer (NSCLC) V Parvathaneni, NS Kulkarni, G Chauhan, SK Shukla, R Elbatanony, ... Materials Science and Engineering: C 115, 111139, 2020 | 32 | 2020 |
| Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation SS Sawant, SM Patil, SK Shukla, NS Kulkarni, V Gupta, NK Kunda Drug Delivery and Translational Research, 1-14, 2022 | 21 | 2022 |
| Nanotechnology based repositioning of an anti-viral drug for non-small cell lung cancer (NSCLC) V Parvathaneni, M Goyal, NS Kulkarni, SK Shukla, V Gupta Pharmaceutical Research 37, 1-21, 2020 | 19 | 2020 |
| Path Analysis in Pigeonpea (Cajanus cajan (L.) Millsp.) in Mid-altitudes of North-western Himalyas V Mahajan, SK Shukla, V Tiwari, SVS Prasad, HS Gupta CROP IMPROVEMENT-INDIA- 34 (1), 56, 2007 | 19 | 2007 |
| Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer S K Shukla, V Nguyen, M Goyal, V Gupta Nanomedicine 17 (13), 935-958, 2022 | 14 | 2022 |
| Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation–Evaluation of intestinal absorption and anti-cancer activity V Parvathaneni, RS Elbatanony, SK Shukla, NS Kulkarni, DD Kanabar, ... Journal of Molecular Liquids 327, 114866, 2021 | 14 | 2021 |
| Inhaled indomethacin-loaded liposomes as potential therapeutics against non-small cell lung cancer (NSCLC) S Sarvepalli, V Parvathaneni, G Chauhan, SK Shukla, V Gupta Pharmaceutical Research 39 (11), 2801-2815, 2022 | 10 | 2022 |
Vivek Gupta, Ph.D.Associate Professor, Pharmaceutical Sciences, St. John's University College of PharmacyVerifierad e-postadress på stjohns.edu
